Agilent, GKPC-402, AdvanceBio InstantPC G0F-N / FA1 N-glycan standard

AdvanceBio InstantPC G0F-N / FA1 N-glycan standard . N-glycan (asialo-, agalacto-, biantennary complex N-glycan -1 N-Acetylglucosamine and with core fucose) labeled with InstantPC, for use as a qualitative standard in applications such as liquid chromatography (LC). Alternative glycan names: G0F-GlcNAc, G0F-GN, F(6)A1, NGA2F-N.

Specifications:
Chemical Structure:
Label: InstantPC
Monoisotopic Mass: MWGlycan + 261.14773 = 1520.6128
Name: G0F-N
Oxford Name: F(6)A1
Standard Type: Complex-type Native N-Glycan
Unit: 25 Injections

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
The AdvanceBio InstantPC G0F-N / FA1 N-glycan standard is a high-quality reference material designed to support accurate and reproducible analysis of N-linked glycan profiles in biopharmaceutical research and quality control. Manufactured to stringent specifications, this standard is optimized for use with capillary electrophoresis and liquid chromatography systems, including Agilent’s 1200 Infinity Series and 1290 Infinity II LC platforms, as well as the 2100 Bioanalyzer and AdvanceBio Glycan Mapping columns. Suitable for laboratories focused on monoclonal antibody characterization, it aids in validating glycan release, labeling, and separation workflows, ensuring reliable glycosylation profiling. The product comes ready-to-use, pre-labeled with InstantPC dye, enabling rapid sample preparation and consistent fluorescence detection. Ideal for method development, system performance validation, and comparative studies, this standard is a critical control for demonstrating system suitability and supporting regulatory documentation. It is fully compatible with Agilent glycan workflow reagents and data analysis solutions, including MassHunter and OpenLab software, facilitating comprehensive data acquisition and reporting. This standard is an essential resource for scientists seeking to achieve robust, high-resolution N-glycan analysis in the development and quality assessment of therapeutic proteins and other glycoprotein-based products.